- Advertisement -

Innovative approach for the development of next-generation cancer therapies targeting FGFR2/3

Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic cholangiocarcinoma, endometrial, breast, gastric, and bladder cancers. However, the development...

Top 15 Best-Selling Drugs Launched in 2020

The additional challenges to launching new drugs that emerged since COVID-19 upended the biopharma industry, and life as we knew it, will continue into...

Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas

A novel treatment for leukemias and lymphomas that arise from immune system T cells,  developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig...

Standardizing Cell and Gene Therapy Remains Bioindustry Goal

For companies working on cell and gene therapies, preparing the reagents required for product development and scale-up can take lots of time and money....

Hevolution Foundation Grant Expands New Investigator Awards in Geroscience

The American Federation for Aging Research (AFAR) received a $16 million grant from the Hevolution Foundation to expand the Hevolution-AFAR New Investigator Awards in Aging...

StockWatch: HHS Review of Bird Flu Contract Sinks Moderna Shares

Moderna (NASDAQ: MRNA) shares have tumbled 31% since January 28, capped by a 7% decline Thursday and a 2% dip Friday in the messenger...

Approaches to Reducing Toxicity and Side Effects in Cell and Gene...

Cell and gene therapy encompasses a broad range of therapeutic interventions for diseases that have proved refractory to treatment with conventional pharmaceutical approaches. Perhaps...

Portable MiniDock MTB delivers tuberculosis results in thirty minutes

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer. A big obstacle...

Approaches to Reducing Toxicity and Side Effects in Cell and Gene Therapy

Cell and gene therapy encompasses a broad range of therapeutic interventions for diseases that have proved refractory to treatment with conventional pharmaceutical approaches. Perhaps...

Portable MiniDock MTB delivers tuberculosis results in thirty minutes

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer. A big obstacle...

Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences

Officials at Ecolab Life Sciences report that the company is expanding its bioprocessing business with the launch of a new bioprocessing applications lab (BPAL)...

more new items

Approaches to Reducing Toxicity and Side Effects in Cell and Gene...

Cell and gene therapy encompasses a broad range of therapeutic interventions for diseases that have proved refractory to treatment with conventional pharmaceutical approaches. Perhaps...

Portable MiniDock MTB delivers tuberculosis results in thirty minutes

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer. A big obstacle...

Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences

Officials at Ecolab Life Sciences report that the company is expanding its bioprocessing business with the launch of a new bioprocessing applications lab (BPAL)...